Quince Therapeutics, Inc. (QNCX) vs TransCode Therapeutics Inc. (RNAZ)

Quince Therapeutics, Inc. and TransCode Therapeutics Inc. are both Biotechnology companies. Quince Therapeutics, Inc. and TransCode Therapeutics Inc. are of similar size ($30.5M and $27.9M). Across the 7 metrics below, Quince Therapeutics, Inc. leads on 5 and TransCode Therapeutics Inc. on 2.

Valuation

Metric QNCX RNAZ Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.15 0.74
EV/Sales n/m n/m 10.73
Earnings yield (459.06%) (3,098.82%) (28.84%)
Free cash flow yield (24.87%) (1,398.93%) (23.03%)

Profitability

Metric QNCX RNAZ Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 784.09% 429.61% (57.72%)
Return on assets (76.68%) (58.12%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric QNCX RNAZ Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) (28.24%) 96.02% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric QNCX RNAZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 14.52 1.97 4.73
Net debt to EBITDA 0.00 0.64 0.96

Dividend

Metric QNCX RNAZ Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric QNCX RNAZ Biotechnology median
Market cap 30.51m 27.94m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack